Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Mostrar mais
Pergunte à ADVFN Intelligence (IA)
| Período | Var | Var % | Abe | Máx. | Mín. | Vol Méd. | VWAP diário | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.121 | -19.175911252 | 0.631 | 0.636 | 0.5113 | 24374 | 0.58528882 | CS |
| 4 | -0.31 | -37.8048780488 | 0.82 | 0.83 | 0.5113 | 59010 | 0.70449569 | CS |
| 12 | -0.237 | -31.7269076305 | 0.747 | 1.1099 | 0.5 | 245816 | 0.87095631 | CS |
| 26 | -1.15 | -69.2771084337 | 1.66 | 1.87 | 0.5 | 122481 | 0.90156284 | CS |
| 52 | -0.3877 | -43.188147488 | 0.8977 | 1.87 | 0.5 | 66318 | 0.91323682 | CS |
| 156 | -7.09 | -93.2894736842 | 7.6 | 9.4 | 0.5 | 62554 | 3.80408987 | CS |
| 260 | -14.45 | -96.5909090909 | 14.96 | 19.56 | 0.5 | 347665 | 10.81610362 | CS |
Suporte: (11) 4950 5808 | suporte@advfn.com.br
Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições
Recursos principais
Premium
